مستقبل مستضد خيمري (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "مستقبل مستضد خيمري" in Arabic language version.

refsWebsite

Global rank Arabic rank

16nih.gov

4^th place

6^th place

11doi.org

2^nd place

5^th place

4web.archive.org

1^st place

1alqamoos.org

low place

316^th place

1cellectis.com

low place

1nbcnews.com

137^th place

567^th place

1harvard.edu

18^th place

33^rd place

1jstor.org

26^th place

31^st place

1technologyreview.com

1,943^rd place

3,743^rd place

1archive-it.org

910^th place

1,495^th place

1fda.gov

447^th place

393^rd place

alqamoos.org

"Al-Qamoos القاموس - English Arabic dictionary / قاموس إنجليزي عربي". www.alqamoos.org. مؤرشف من الأصل في 2018-08-18. اطلع عليه بتاريخ 2018-08-18.

archive-it.org

wayback.archive-it.org

(بالإنجليزية) Emily Mullin, « A pioneering gene therapy for leukemia has arrived in the U.S. », في MIT Technology Review, août 2017 [النص الكامل (pages consultées le 2018-08-09)] "نسخة مؤرشفة". مؤرشف من الأصل في 2017-09-10. اطلع عليه بتاريخ 2018-08-18.{{استشهاد ويب}}: صيانة الاستشهاد: BOT: original URL status unknown (link)

cellectis.com

"CAR Récepteur antigénique chimérique | cellectis". www.cellectis.com (بالفرنسية). Archived from the original on 2017-04-29. Retrieved 2018-08-08. نسخة محفوظة 27 فبراير 2015 على موقع واي باك مشين.

doi.org

Sadelain M، Brentjens R، Rivière I (أبريل 2013). "The basic principles of chimeric antigen receptor design". Cancer Discovery. ج. 3 ع. 4: 388–98. DOI:10.1158/2159-8290.CD-12-0548. PMC:3667586. PMID:23550147.
Hartmann J، Schüßler-Lenz M، Bondanza A، Buchholz CJ (سبتمبر 2017). "Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts". EMBO Molecular Medicine. ج. 9 ع. 9: 1183–1197. DOI:10.15252/emmm.201607485. PMC:5582407. PMID:28765140.
Srivastava S، Riddell SR (أغسطس 2015). "Engineering CAR-T cells: Design concepts". Trends in Immunology. ج. 36 ع. 8: 494–502. DOI:10.1016/j.it.2015.06.004. PMC:4746114. PMID:26169254.
Rosenbaum L (أكتوبر 2017). "Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy". The New England Journal of Medicine. ج. 377 ع. 14: 1313–1315. DOI:10.1056/NEJMp1711886. PMID:28902570.
Gross G، Waks T، Eshhar Z (ديسمبر 1989). "Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity". Proceedings of the National Academy of Sciences of the United States of America. ج. 86 ع. 24: 10024–8. Bibcode:1989PNAS...8610024G. DOI:10.1073/pnas.86.24.10024. JSTOR:34790. PMC:298636. PMID:2513569.
Casucci M، Bondanza A (2011). "Suicide gene therapy to increase the safety of chimeric antigen receptor-redirected T lymphocytes". Journal of Cancer. ج. 2: 378–82. DOI:10.7150/jca.2.378. PMC:3133962. PMID:21750689.
Hartmann J، Schüßler-Lenz M، Bondanza A، Buchholz CJ (2017). "Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts". EMBO Molecular Medicine. ج. 9 ع. 9: 1183–1197. DOI:10.15252/emmm.201607485.
Chmielewski M، Abken H (2015). "TRUCKs: the fourth generation of CARs". Expert Opin Biol. ج. 15 ع. 8: 1145–1154. DOI:10.1517/14712598.2015.1046430.
Rudd CE، Schneider H (يوليو 2003). "Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling". Nature Reviews. Immunology. ج. 3 ع. 7: 544–56. DOI:10.1038/nri1131. PMID:12876557.
Rudd CE (يناير 1999). "Adaptors and molecular scaffolds in immune cell signaling". Cell. ج. 96 ع. 1: 5–8. DOI:10.1016/S0092-8674(00)80953-8. PMID:9989491.
Sadelain M، Brentjens R، Rivière I (أبريل 2009). "The promise and potential pitfalls of chimeric antigen receptors". Current Opinion in Immunology. ج. 21 ع. 2: 215–23. DOI:10.1016/j.coi.2009.02.009. PMC:5548385. PMID:19327974.

fda.gov

"Press Announcements - FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma". www.fda.gov (بالإنجليزية). Archived from the original on 2019-04-25. Retrieved 2018-08-09. {{استشهاد ويب}}: الوسيط غير المعروف |nom1= تم تجاهله يقترح استخدام |last1= (help)

harvard.edu

ui.adsabs.harvard.edu

Gross G، Waks T، Eshhar Z (ديسمبر 1989). "Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity". Proceedings of the National Academy of Sciences of the United States of America. ج. 86 ع. 24: 10024–8. Bibcode:1989PNAS...8610024G. DOI:10.1073/pnas.86.24.10024. JSTOR:34790. PMC:298636. PMID:2513569.

jstor.org

Gross G، Waks T، Eshhar Z (ديسمبر 1989). "Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity". Proceedings of the National Academy of Sciences of the United States of America. ج. 86 ع. 24: 10024–8. Bibcode:1989PNAS...8610024G. DOI:10.1073/pnas.86.24.10024. JSTOR:34790. PMC:298636. PMID:2513569.

nbcnews.com

Fox، Maggie (12 يوليو 2017). "New Gene Therapy for Cancer Offers Hope to Those With No Options Left". NBC News. مؤرشف من الأصل في 2019-05-23.

nih.gov

pubmed.ncbi.nlm.nih.gov

Sadelain M، Brentjens R، Rivière I (أبريل 2013). "The basic principles of chimeric antigen receptor design". Cancer Discovery. ج. 3 ع. 4: 388–98. DOI:10.1158/2159-8290.CD-12-0548. PMC:3667586. PMID:23550147.
Hartmann J، Schüßler-Lenz M، Bondanza A، Buchholz CJ (سبتمبر 2017). "Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts". EMBO Molecular Medicine. ج. 9 ع. 9: 1183–1197. DOI:10.15252/emmm.201607485. PMC:5582407. PMID:28765140.
Srivastava S، Riddell SR (أغسطس 2015). "Engineering CAR-T cells: Design concepts". Trends in Immunology. ج. 36 ع. 8: 494–502. DOI:10.1016/j.it.2015.06.004. PMC:4746114. PMID:26169254.
Gross G، Gorochov G، Waks T، Eshhar Z (فبراير 1989). "Generation of effector T cells expressing chimeric T cell receptor with antibody type-specificity". Transplantation Proceedings. ج. 21 ع. 1 Pt 1: 127–30. PMID:2784887.
Rosenbaum L (أكتوبر 2017). "Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy". The New England Journal of Medicine. ج. 377 ع. 14: 1313–1315. DOI:10.1056/NEJMp1711886. PMID:28902570.
Gross G، Waks T، Eshhar Z (ديسمبر 1989). "Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity". Proceedings of the National Academy of Sciences of the United States of America. ج. 86 ع. 24: 10024–8. Bibcode:1989PNAS...8610024G. DOI:10.1073/pnas.86.24.10024. JSTOR:34790. PMC:298636. PMID:2513569.
Casucci M، Bondanza A (2011). "Suicide gene therapy to increase the safety of chimeric antigen receptor-redirected T lymphocytes". Journal of Cancer. ج. 2: 378–82. DOI:10.7150/jca.2.378. PMC:3133962. PMID:21750689.
Rudd CE، Schneider H (يوليو 2003). "Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling". Nature Reviews. Immunology. ج. 3 ع. 7: 544–56. DOI:10.1038/nri1131. PMID:12876557.
Rudd CE (يناير 1999). "Adaptors and molecular scaffolds in immune cell signaling". Cell. ج. 96 ع. 1: 5–8. DOI:10.1016/S0092-8674(00)80953-8. PMID:9989491.
Sadelain M، Brentjens R، Rivière I (أبريل 2009). "The promise and potential pitfalls of chimeric antigen receptors". Current Opinion in Immunology. ج. 21 ع. 2: 215–23. DOI:10.1016/j.coi.2009.02.009. PMC:5548385. PMID:19327974.

ncbi.nlm.nih.gov

Sadelain M، Brentjens R، Rivière I (أبريل 2013). "The basic principles of chimeric antigen receptor design". Cancer Discovery. ج. 3 ع. 4: 388–98. DOI:10.1158/2159-8290.CD-12-0548. PMC:3667586. PMID:23550147.
Hartmann J، Schüßler-Lenz M، Bondanza A، Buchholz CJ (سبتمبر 2017). "Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts". EMBO Molecular Medicine. ج. 9 ع. 9: 1183–1197. DOI:10.15252/emmm.201607485. PMC:5582407. PMID:28765140.
Srivastava S، Riddell SR (أغسطس 2015). "Engineering CAR-T cells: Design concepts". Trends in Immunology. ج. 36 ع. 8: 494–502. DOI:10.1016/j.it.2015.06.004. PMC:4746114. PMID:26169254.
Gross G، Waks T، Eshhar Z (ديسمبر 1989). "Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity". Proceedings of the National Academy of Sciences of the United States of America. ج. 86 ع. 24: 10024–8. Bibcode:1989PNAS...8610024G. DOI:10.1073/pnas.86.24.10024. JSTOR:34790. PMC:298636. PMID:2513569.
Casucci M، Bondanza A (2011). "Suicide gene therapy to increase the safety of chimeric antigen receptor-redirected T lymphocytes". Journal of Cancer. ج. 2: 378–82. DOI:10.7150/jca.2.378. PMC:3133962. PMID:21750689.
Sadelain M، Brentjens R، Rivière I (أبريل 2009). "The promise and potential pitfalls of chimeric antigen receptors". Current Opinion in Immunology. ج. 21 ع. 2: 215–23. DOI:10.1016/j.coi.2009.02.009. PMC:5548385. PMID:19327974.

technologyreview.com

(بالإنجليزية) Emily Mullin, « A pioneering gene therapy for leukemia has arrived in the U.S. », في MIT Technology Review, août 2017 [النص الكامل (pages consultées le 2018-08-09)] "نسخة مؤرشفة". مؤرشف من الأصل في 2017-09-10. اطلع عليه بتاريخ 2018-08-18.{{استشهاد ويب}}: صيانة الاستشهاد: BOT: original URL status unknown (link)

web.archive.org

"Al-Qamoos القاموس - English Arabic dictionary / قاموس إنجليزي عربي". www.alqamoos.org. مؤرشف من الأصل في 2018-08-18. اطلع عليه بتاريخ 2018-08-18.
"CAR Récepteur antigénique chimérique | cellectis". www.cellectis.com (بالفرنسية). Archived from the original on 2017-04-29. Retrieved 2018-08-08. نسخة محفوظة 27 فبراير 2015 على موقع واي باك مشين.
Fox، Maggie (12 يوليو 2017). "New Gene Therapy for Cancer Offers Hope to Those With No Options Left". NBC News. مؤرشف من الأصل في 2019-05-23.
"Press Announcements - FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma". www.fda.gov (بالإنجليزية). Archived from the original on 2019-04-25. Retrieved 2018-08-09. {{استشهاد ويب}}: الوسيط غير المعروف |nom1= تم تجاهله يقترح استخدام |last1= (help)